Skip to main content
63°
Partly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Acadia Pharmaceutica
(NQ:
ACAD
)
14.88
-0.22 (-1.46%)
Streaming Delayed Price
Updated: 12:39 PM EDT, May 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Acadia Pharmaceutica
< Previous
1
2
3
4
5
6
7
8
9
Next >
Shhh! 3 Secret Penny Stocks Flying Below Wall Street’s Radar
May 09, 2024
Under-the-radar penny stocks can be some of the most rewarding investments on the market. Here are three to consider.
Via
InvestorPlace
ACAD Stock Earnings: ACADIA Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024
May 08, 2024
ACAD stock results show that ACADIA Pharmaceuticals beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
ACADIA Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (25 Ratings)
April 30, 2024
Via
Benzinga
3 Pharma Stocks to Sell in April Before They Crash & Burn
April 11, 2024
Discover three pharma stocks to sell in April, facing challenges and signaling potential for significant downside.
Via
InvestorPlace
Cracking The Code: Understanding Analyst Reviews For ACADIA Pharmaceuticals
April 10, 2024
Via
Benzinga
Expert Ratings For ACADIA Pharmaceuticals
March 25, 2024
Via
Benzinga
Beyond The Numbers: 13 Analysts Discuss ACADIA Pharmaceuticals Stock
February 28, 2024
Via
Benzinga
Recap: ACADIA Pharmaceuticals Q4 Earnings
February 27, 2024
Via
Benzinga
Earnings Scheduled For February 27, 2024
February 27, 2024
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.
Via
Benzinga
Analyst Scoreboard: 12 Ratings For ACADIA Pharmaceuticals
January 24, 2024
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
March 19, 2024
Via
Benzinga
3 Pharma Stocks to Sell in March Before They Crash & Burn
March 14, 2024
Discover top pharma stocks to sell in March before they plummet. Learn why ACAD, AMLX and WST are on the list for urgent sell-off decisions.
Via
InvestorPlace
Why Are Airline Stocks Down Today?
March 12, 2024
Airline stocks are down on Tuesday as investors deal with several bits of bad news for the industry on Tuesday!
Via
InvestorPlace
Why Is Acadia Pharmaceuticals (ACAD) Stock Down 18% Today?
March 12, 2024
Acadia Pharmaceuticals stock is falling on Tuesday as investors in ACAD react to its failed Phase 3 clinical trial of pimavanserin.
Via
InvestorPlace
Oracle To Rally Around 40%? Here Are 10 Top Analyst Forecasts For Tuesday
March 12, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Deep Dive Into ACADIA Pharmaceuticals Stock: Analyst Perspectives (13 Ratings)
December 29, 2023
Via
Benzinga
Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 12, 2024
Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance.
Via
Benzinga
Acadia Hits 11-Month Low After Outsized Placebo Effect Torpedoes Schizophrenia Study
March 12, 2024
The company says it doesn't plan to further develop Nuplazid in clinical testing.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 12, 2024
Via
Benzinga
Why Oracle Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
March 12, 2024
Shares of Oracle Corporation (NYSE: ORCL) rose sharply in today’s pre-market trading after the company reported upbeat earnings for its fis
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
March 12, 2024
Pre-market stock movers are worth checking out this morning as we get into all of the biggest winners and losers for Tuesday!
Via
InvestorPlace
Trial Setback For Acadia Pharmaceuticals' Late-Stage Schizophrenia Trial: Details
March 12, 2024
Acadia Pharmaceuticals' Phase 3 ADVANCE-2 trial results on pimavanserin for schizophrenia-negative symptoms. Insights on efficacy, safety, and future considerations.
Via
Benzinga
ACADIA Pharmaceuticals, Ocular Therapeutix, Asana And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
March 12, 2024
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining by around 50 points on Tuesday.
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
March 11, 2024
Via
Benzinga
3 Stock Winners That Are Up 1,000% or More in 2024
March 08, 2024
Dig deep enough, and find a story hot enough, and you can uncover potential stock winners up 1,000%. Here are three.
Via
InvestorPlace
Acadia Stock Dives As Unexpected Seasonality Rocks Its Most High-Profile Launch
February 28, 2024
CEO Steve Davis said there was a lot of pent-up demand when Daybue first launched last year.
Via
Investor's Business Daily
The 3 Most Undervalued Biotech Stocks to Buy in February 2024
February 08, 2024
With patience, some of the most undervalued biotech stocks can create massive wealth, such as these three to consider.
Via
InvestorPlace
Expedia To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Friday
December 29, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Acadia Soars To A Four-Month High After Winning A Patent Battle For Its Biggest Drug
December 13, 2023
MSN Labs lost out in a summary judgement to knock off Acadia's Nuplazid.
Via
Investor's Business Daily
Topics
Intellectual Property
Exposures
Intellectual Property
What's Going On With Acadia Pharmaceuticals Stock?
December 13, 2023
Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) shares are trading higher Wednesday after the company won summary judgement in a patent suit regarding its Nuplazid drug. What To Know:
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.